Related Experiment Video
Updated: Jun 20, 2026

Electrophysiological Measurements and Analysis of Nociception in Human Infants
Published on: December 20, 2011
Ethical and safety aspects of clinical trials in neonates
1Academic Division of Child Health, University of Nottingham, Derbyshire Children's Hospital, Derby DE22 3DT, UK. imti.choonara@nottingham.ac.uk
Insights
Clinical trials in neonates are crucial for establishing drug efficacy and safety. New European legislation aims to boost neonatal research, leading to more licensed medicines and emphasizing safe, ethical trial practices.
Area of Science:
- Neonatal pharmacology
- Pediatric clinical research
- Drug safety and efficacy
Background:
- Clinical trials in neonates are vital for evidence-based medicine.
- Recent European legislation aims to increase research in this population.
- Understanding neonatal drug toxicity is critical for safe trials.
Purpose of the Study:
- To highlight the importance of clinical trials in neonates.
- To discuss the impact of new European legislation on neonatal drug research.
- To emphasize the need for awareness of factors predisposing neonates to drug toxicity.
Main Methods:
- Review of European legislation concerning pediatric drug development.
- Analysis of the importance of neonatal clinical trials.
- Discussion of predisposing factors for drug toxicity in neonates.
Main Results:
- European legislation is expected to stimulate more clinical research in neonates.
- Increased research may lead to a greater number of licensed medicines for neonatal use.
- Awareness of specific neonatal vulnerabilities is essential for safe and ethical trial conduct.
Conclusions:
- Clinical trials in neonates are indispensable for ensuring drug safety and efficacy.
- New legislative initiatives are poised to enhance the landscape of neonatal medicine.
- Prioritizing safe and ethical trial conduct, including understanding toxicity factors, is paramount.
Abstract:
Clinical trials in neonates are essential in order to provide scientific evidence in relation to the efficacy and safety of medicines. European legislation has recently been passed in order to stimulate clinical research in this area. This should hopefully result in more licensed medicines in the neonatal period. It is essential that the clinical trials are performed safely and ethically and one therefore needs to be aware of predisposing factors for drug toxicity in the neonatal period.
More Related Videos
Related Concept Videos
Clinical Trials
There are four phases in a clinical trial. A phase one...
Clinical Trials: Overview
Ethical Dilemmas I
Let us explore some examples to understand the potentially complex moral decisions nurses face.
Take the case of caring for minors, particularly in areas related to reproductive...
Pharmacokinetics in Pediatric Patients: Drug Excretion
Pharmacokinetics in Pediatric Patients: Drug Distribution
Preclinical Development: Overview

